Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1
- PMID: 20372119
- DOI: 10.1038/ajg.2009.678
Evaluating a bacterial hypothesis in IBS using a modification of Koch's postulates: part 1
Abstract
It has recently been suggested that irritable bowel syndrome (IBS) symptoms are due partly to small intestinal bacterial overgrowth (SIBO). This "SIBO hypothesis" has led to the use of antibiotics to treat IBS. Koch's postulates have long been used to establish bacteria as a cause of diseases such as tuberculosis. Because SIBO is not a single organism, we use modified Koch's postulates to argue for antibiotics and an SIBO hypothesis in the pathophysiology of IBS. We show that there is evidence for SIBO, that it is culturable, that antibiotic elimination of the bacteria improves subjects clinically, and that when the bacteria return, the symptoms return. On the basis of proof of a bacterial cause of IBS, antibiotics may be a good choice of therapy.
Similar articles
-
Questioning the bacterial overgrowth hypothesis of irritable bowel syndrome: an epidemiologic and evolutionary perspective.Clin Gastroenterol Hepatol. 2011 Jun;9(6):461-9; quiz e59. doi: 10.1016/j.cgh.2011.02.030. Epub 2011 Mar 11. Clin Gastroenterol Hepatol. 2011. PMID: 21397724 Review.
-
Bacterial concepts in irritable bowel syndrome.Rev Gastroenterol Disord. 2005;5 Suppl 3:S3-9. Rev Gastroenterol Disord. 2005. PMID: 17713456 Review.
-
Small intestinal bacterial overgrowth in patients with irritable bowel syndrome.Gut. 2007 Jun;56(6):802-8. doi: 10.1136/gut.2006.108712. Epub 2006 Dec 5. Gut. 2007. PMID: 17148502 Free PMC article.
-
The small intestinal bacterial overgrowth. Irritable bowel syndrome hypothesis: implications for treatment.Gut. 2008 Sep;57(9):1315-21. doi: 10.1136/gut.2007.133629. Epub 2008 Feb 4. Gut. 2008. PMID: 18250127 Review. No abstract available.
-
Prevalence of small intestinal bacterial overgrowth in children with irritable bowel syndrome: a case-control study.J Pediatr. 2009 Sep;155(3):416-20. doi: 10.1016/j.jpeds.2009.03.033. Epub 2009 Jun 16. J Pediatr. 2009. PMID: 19535093
Cited by
-
Targeting the Gut Microbiota to Relieve the Symptoms of Irritable Bowel Syndrome.Pathogens. 2021 Nov 25;10(12):1545. doi: 10.3390/pathogens10121545. Pathogens. 2021. PMID: 34959500 Free PMC article. Review.
-
The microbiota-gut-brain axis in functional gastrointestinal disorders.Gut Microbes. 2014 May-Jun;5(3):419-29. doi: 10.4161/gmic.29417. Epub 2014 Jun 12. Gut Microbes. 2014. PMID: 24921926 Free PMC article. Review.
-
Antibiotics for irritable bowel syndrome: rationale and current evidence.Curr Gastroenterol Rep. 2012 Oct;14(5):439-45. doi: 10.1007/s11894-012-0284-2. Curr Gastroenterol Rep. 2012. PMID: 22945316 Review.
-
Antibiotics for the treatment of irritable bowel syndrome.Gastroenterol Hepatol (N Y). 2011 Jul;7(7):455-93. Gastroenterol Hepatol (N Y). 2011. PMID: 22298980 Free PMC article.
-
Gastrointestinal microbiome signatures of pediatric patients with irritable bowel syndrome.Gastroenterology. 2011 Nov;141(5):1782-91. doi: 10.1053/j.gastro.2011.06.072. Epub 2011 Jul 8. Gastroenterology. 2011. PMID: 21741921 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical